Parsons Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Parsons Capital Management Inc

$1.7 Billion
Q3 2025

A detailed history of Parsons Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Parsons Capital Management Inc holds 9,886 shares of VRTX stock, worth $4.29 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

9,886

Previous 10,428 5.2%

Holding current value

$4.29 Million

Previous $4.64 Million 16.61%

% of portfolio

0.23%

Previous 0.29%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$366.54 - $479.53 $198,664 - $259,905	-542 Reduced 5.2%	9,886 $3.87 Million
Q2 2025 Jul 18, 2025	BUY	$421.16 - $509.5 $1.12 Million - $1.36 Million	2,660 Added 34.24%	10,428 $4.64 Million
Q1 2025 Apr 15, 2025	BUY	$402.49 - $513.76 $295,830 - $377,613	735 Added 10.45%	7,768 $3.77 Million
Q4 2024 Jan 22, 2025	BUY	$396.64 - $516.74 $603,289 - $785,961	1,521 Added 27.59%	7,033 $2.83 Million
Q3 2024 Nov 04, 2024	BUY	$460.0 - $505.78 $115,000 - $126,445	250 Added 4.75%	5,512 $2.56 Million

Q2 2024 Jul 19, 2024	BUY	$392.81 - $485.53 $1.02 Million - $1.26 Million	2,591 Added 97.0%	5,262 $2.47 Million
Q1 2024 Apr 22, 2024	BUY	$407.69 - $446.08 $768,087 - $840,414	1,884 Added 239.39%	2,671 $1.12 Million
Q4 2023 Jan 22, 2024	BUY	$343.0 - $410.68 $34,300 - $41,068	100 Added 14.56%	787 $320,000
Q2 2023 Aug 04, 2023	SELL	$314.42 - $351.91 $628 - $703	-2 Reduced 0.29%	687 $241,000
Q1 2023 Apr 17, 2023	BUY	$283.23 - $323.1 $195,145 - $222,615	689 New	689 $217,000
Q4 2021 Feb 07, 2022	SELL	$177.01 - $223.45 $224,448 - $283,334	-1,268 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $257,573 - $288,245	-1,420 Reduced 52.83%	1,268 $230,000
Q2 2021 Aug 03, 2021	SELL	$187.49 - $221.1 $135,555 - $159,855	-723 Reduced 21.2%	2,688 $542,000
Q1 2021 Apr 28, 2021	SELL	$207.02 - $241.31 $541,978 - $631,749	-2,618 Reduced 43.42%	3,411 $733,000
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $14,490 - $19,326	-70 Reduced 1.15%	6,029 $1.43 Million
Q3 2020 Oct 29, 2020	BUY	$255.65 - $303.1 $105,327 - $124,877	412 Added 7.24%	6,099 $1.66 Million
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $77,790 - $102,051	345 Added 6.46%	5,687 $1.65 Million
Q1 2020 May 05, 2020	BUY	$199.77 - $247.81 $1.07 Million - $1.32 Million	5,342 New	5,342 $1.27 Million

Others Institutions Holding VRTX

# of Institutions

1,791

Shares Held

231M

Call Options Held

1.84M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Account

Parsons Capital Management Inc Vertex Pharmaceuticals Inc Transaction History